These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2964166)

  • 21. Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN.
    Stoof JC; Horn AS; Mulder AH
    Brain Res; 1980 Aug; 196(1):276-81. PubMed ID: 7397528
    [No Abstract]   [Full Text] [Related]  

  • 22. Indirect central 5-hydroxytryptaminergic actions of methoxy substituted 2-aminotetralin derivatives.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Lindberg P; Wikström H; Svensson K; Hjorth S; Carlsson A
    Acta Pharm Suec; 1986; 23(2):77-90. PubMed ID: 3739739
    [No Abstract]   [Full Text] [Related]  

  • 23. The dopamine D3 receptor: Chinese hamsters or Chinese whispers?
    Large CH; Stubbs CM
    Trends Pharmacol Sci; 1994 Feb; 15(2):46-7. PubMed ID: 8165723
    [No Abstract]   [Full Text] [Related]  

  • 24. Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.
    Cannon JG; Lee T; Goldman HD
    J Med Chem; 1977 Sep; 20(9):1111-6. PubMed ID: 562941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions.
    Cannon JG; Brubaker AN; Long JP; Flynn JR; Verimer T; Harnirattisai P; Costall B; Naylor RJ; Nohria V
    J Med Chem; 1981 Feb; 24(2):149-53. PubMed ID: 7205882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of some [N-(2-haloalkyl)amino]tetralin derivatives as potential irreversible labels for bovine anterior pituitary D2 dopamine receptors.
    Hall AW; Taylor RJ; Simmonds SH; Strange PG
    J Med Chem; 1987 Oct; 30(10):1879-87. PubMed ID: 3656361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topographical analysis of the actions of 2(N,N-dipropyl)amino-5,6-dihydroxytetralin to cause biting behaviour and locomotor hyperactivity from the striatum of the guinea-pig.
    Costall B; De Souza CX; Naylor RJ
    Neuropharmacology; 1980 Jul; 19(7):623-31. PubMed ID: 7190654
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminotetralins as narcotic antagonists. 2. Synthesis and opiate-related activity of 1-phenyl-3-aminotetralins.
    Fries DS; Bertelli DJ
    J Med Chem; 1982 Mar; 25(3):216-20. PubMed ID: 6121915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine agonists: structure-activity relationships.
    Cannon JG
    Prog Drug Res; 1985; 29():303-414. PubMed ID: 3911262
    [No Abstract]   [Full Text] [Related]  

  • 30. alpha-Adrenergic agents. 2. Synthesis and alpha 1-agonist activity of 2-aminotetralins.
    DeMarinis RM; Shah DH; Hall RF; Hieble JP; Pendleton RG
    J Med Chem; 1982 Feb; 25(2):136-41. PubMed ID: 6120238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the structure-activity relationship of adrenergic beta-mimetic benzylamine derivatives. IV.1) Aryl-substituted 1-aminotetralins and 1-aminoindans.
    Yamamura S; Oda K; Mizoguchi T; Saito S; Iwasawa Y; Ohashi M; Kiyomoto A
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3613-23. PubMed ID: 34486
    [No Abstract]   [Full Text] [Related]  

  • 32. 2-amino-6,7-dihydroxytetrahydronaphthalene and the receptor-site preferred conformation of dopamine--a commentary.
    Horn AS; Rodgers JR
    J Pharm Pharmacol; 1980 Jul; 32(7):521-4. PubMed ID: 6105198
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis of 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists.
    Grosso JA; Nichols DE; Kohli JD; Glock D
    J Med Chem; 1982 Jun; 25(6):703-8. PubMed ID: 7097723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The beta-adrenomimetic activity of tetrahydroisoquinolines and tetrahydronaphthalenes.
    Beaumont D; Waigh RD
    Prog Med Chem; 1981; 18():45-86. PubMed ID: 6124026
    [No Abstract]   [Full Text] [Related]  

  • 35. The preparation and pharmacological properties of 3-acetyltyrosine and 3-acetyltyramine.
    Florvall L; Ross SB; Ogren SO; Stjernström NE
    Acta Pharm Suec; 1978; 15(1):13-22. PubMed ID: 645365
    [No Abstract]   [Full Text] [Related]  

  • 36. Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors?
    Testa B; Jenner P; Kilpatrick GJ; el Tayar N; Van de Waterbeemd H; Marsden CD
    Biochem Pharmacol; 1987 Dec; 36(23):4041-6. PubMed ID: 2961342
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrostatic potential images of drugs targetting dopamine receptors.
    Hirono S; Umeyama H; Moriguchi I
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3061-5. PubMed ID: 6518587
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological studies on Helix neuron octopamine receptors.
    Batta S; Walker RJ; Woodruff GN
    Comp Biochem Physiol C Comp Pharmacol; 1979; 64(1):43-51. PubMed ID: 41675
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine D2-receptor affinities of resolved C1-dimethylated 2-aminotetralins.
    Krotowska A; Nordvall G; Mellin C; Johansson AM; Hacksell U
    Acta Pharm Suec; 1987; 24(4):145-52. PubMed ID: 2964166
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.
    Beart PM; Cook CJ; Cincotta M; de Vries DJ; Tepper P; Dijkstra D; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):487-93. PubMed ID: 2963964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.